These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1939140)

  • 21. Dual mechanisms for the low plasma levels of truncated apolipoprotein B proteins in familial hypobetalipoproteinemia. Analysis of a new mouse model with a nonsense mutation in the Apob gene.
    Kim E; Cham CM; Véniant MM; Ambroziak P; Young SG
    J Clin Invest; 1998 Mar; 101(6):1468-77. PubMed ID: 9502790
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liver-specific overexpression of scavenger receptor BI decreases levels of very low density lipoprotein ApoB, low density lipoprotein ApoB, and high density lipoprotein in transgenic mice.
    Wang N; Arai T; Ji Y; Rinninger F; Tall AR
    J Biol Chem; 1998 Dec; 273(49):32920-6. PubMed ID: 9830042
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of a critical lysine residue in apolipoprotein B-100 that mediates noncovalent interaction with apolipoprotein(a).
    Becker L; McLeod RS; Marcovina SM; Yao Z; Koschinsky ML
    J Biol Chem; 2001 Sep; 276(39):36155-62. PubMed ID: 11473115
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutation of lysine residues in apolipoprotein B-100 causes defective lipoprotein[a] formation.
    Liu CY; Broadhurst R; Marcovina SM; McCormick SP
    J Lipid Res; 2004 Jan; 45(1):63-70. PubMed ID: 13130121
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Primary sequence mapping of human apolipoprotein B-100 epitopes. Comparisons of trypsin accessibility and immunoreactivity and implication for apoB conformation.
    Chen PF; Marcel YL; Yang CY; Gotto AM; Milne RW; Sparrow JT; Chan L
    Eur J Biochem; 1988 Jul; 175(1):111-8. PubMed ID: 2456922
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Liver LDL receptor mRNA expression is decreased in human ApoB/CETP double transgenic mice and is regulated by diet as well as the cytokine oncostatin M.
    Liu J; Zhang YL; Spence MJ; Vestal RE; Wallace PM; Grass DS
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2948-54. PubMed ID: 9409281
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overexpression of human apolipoprotein B-100 in transgenic rabbits results in increased levels of LDL and decreased levels of HDL.
    Fan J; McCormick SP; Krauss RM; Taylor S; Quan R; Taylor JM; Young SG
    Arterioscler Thromb Vasc Biol; 1995 Nov; 15(11):1889-99. PubMed ID: 7583569
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interactions of low density lipoprotein2 and other apolipoprotein B-containing lipoproteins with lipoprotein(a).
    Ye SQ; Trieu VN; Stiers DL; McConathy WJ
    J Biol Chem; 1988 May; 263(13):6337-43. PubMed ID: 2966154
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A targeted apolipoprotein B-38.9-producing mutation causes fatty livers in mice due to the reduced ability of apolipoprotein B-38.9 to transport triglycerides.
    Chen Z; Fitzgerald RL; Averna MR; Schonfeld G
    J Biol Chem; 2000 Oct; 275(42):32807-15. PubMed ID: 10893242
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of human apolipoprotein B100 in transgenic mice. Editing of human apolipoprotein B100 mRNA.
    Chiesa G; Johnson DF; Yao Z; Innerarity TL; Mahley RW; Young SG; Hammer RH; Hobbs HH
    J Biol Chem; 1993 Nov; 268(32):23747-50. PubMed ID: 8226902
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic evidence that the putative receptor binding domain of apolipoprotein B (residues 3130 to 3630) is not the only region of the protein involved in interaction with the low density lipoprotein receptor.
    Dunning AM; Houlston R; Frostegård J; Revill J; Nilsson J; Hamsten A; Talmud P; Humphries S
    Biochim Biophys Acta; 1991 Apr; 1096(3):231-7. PubMed ID: 2018797
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overexpression of hepatic lipase in transgenic mice decreases apolipoprotein B-containing and high density lipoproteins. Evidence that hepatic lipase acts as a ligand for lipoprotein uptake.
    Dichek HL; Brecht W; Fan J; Ji ZS; McCormick SP; Akeefe H; Conzo L; Sanan DA; Weisgraber KH; Young SG; Taylor JM; Mahley RW
    J Biol Chem; 1998 Jan; 273(4):1896-903. PubMed ID: 9442022
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dietary cholate increases plasma levels of apolipoprotein B in mice by posttranscriptional mechanisms.
    Srivastava RA; Averna M; Srivastava N; Pape ME
    Int J Biochem Cell Biol; 2001 Dec; 33(12):1215-26. PubMed ID: 11606258
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of low density lipoprotein receptor binding domains of human apolipoprotein B-100: a proposed consensus LDL receptor binding sequence of apoB-100.
    Hospattankar AV; Law SW; Lackner K; Brewer HB
    Biochem Biophys Res Commun; 1986 Sep; 139(3):1078-85. PubMed ID: 3767991
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An expression system for human apolipoprotein B100 in a rat hepatoma cell line.
    Blackhart BD; Yao ZM; McCarthy BJ
    J Biol Chem; 1990 May; 265(15):8358-60. PubMed ID: 2341386
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proteolytic degradation of low-density lipoprotein by lipoprotein(a) and by recombinant apo(a).
    Pursiainen M; Jauhiainen M; Kovanen PT; Ehnholm C
    Chem Phys Lipids; 1994 Jan; 67-68():25-33. PubMed ID: 8187221
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Binding of low density lipoproteins to lipoprotein lipase is dependent on lipids but not on apolipoprotein B.
    Boren J; Lookene A; Makoveichuk E; Xiang S; Gustafsson M; Liu H; Talmud P; Olivecrona G
    J Biol Chem; 2001 Jul; 276(29):26916-22. PubMed ID: 11331277
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Site-specific mutagenesis demonstrates that cysteine 4326 of apolipoprotein B is required for covalent linkage with apolipoprotein (a) in vivo.
    Callow MJ; Rubin EM
    J Biol Chem; 1995 Oct; 270(41):23914-7. PubMed ID: 7592581
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transgenic mice expressing human apoB100 and apoB48.
    Young SG; Farese RV; Pierotti VR; Taylor S; Grass DS; Linton MF
    Curr Opin Lipidol; 1994 Apr; 5(2):94-101. PubMed ID: 8044422
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Primary structure of apoB-100.
    Yang C; Gu ZW; Yang M; Gotto AM
    Chem Phys Lipids; 1994 Jan; 67-68():99-104. PubMed ID: 8187250
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.